Literature DB >> 26163925

The weight of obesity on the human immune response to vaccination.

Scott D Painter1, Inna G Ovsyannikova1, Gregory A Poland2.   

Abstract

Despite the high success of protection against several infectious diseases through effective vaccines, some sub-populations have been observed to respond poorly to vaccines, putting them at increased risk for vaccine-preventable diseases. In particular, the limited data concerning the effect of obesity on vaccine immunogenicity and efficacy suggests that obesity is a factor that increases the likelihood of a poor vaccine-induced immune response. Obesity occurs through the deposition of excess lipids into adipose tissue through the production of adipocytes, and is defined as a body-mass index (BMI) ≥ 30 kg/m(2). The immune system is adversely affected by obesity, and these "immune consequences" raise concern for the lack of vaccine-induced immunity in the obese patient requiring discussion of how this sub-population might be better protected.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Communicable diseases; Immunity; Immunization; Obesity; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 26163925      PMCID: PMC4547886          DOI: 10.1016/j.vaccine.2015.06.101

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  89 in total

1.  Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine.

Authors:  Hye-Lim Park; Seung-Hyun Shim; Eun-Young Lee; Whajung Cho; Sooho Park; Hyun-Jung Jeon; Sun-Young Ahn; Hun Kim; Jae-Hwan Nam
Journal:  Hum Vaccin Immunother       Date:  2014-03-10       Impact factor: 3.452

2.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

Review 3.  Energy intake and response to infection with influenza.

Authors:  Elizabeth M Gardner; Eleni Beli; Jonathan F Clinthorne; David M Duriancik
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

4.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

5.  Interactive changes between macrophages and adipocytes.

Authors:  Linglin Xie; M Teresa Ortega; Silvia Mora; Stephen K Chapes
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

6.  Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus.

Authors:  Alexia G Smith; Patricia A Sheridan; Joyce B Harp; Melinda A Beck
Journal:  J Nutr       Date:  2007-05       Impact factor: 4.798

7.  Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes.

Authors:  J J M Bouwman; R J A Diepersloot; F L J Visseren
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

8.  Viral pneumonitis is increased in obese patients during the first wave of pandemic A(H1N1) 2009 virus.

Authors:  Jen Kok; Christopher C Blyth; Hong Foo; Michael J Bailey; David V Pilcher; Steven A Webb; Ian M Seppelt; Dominic E Dwyer; Jonathan R Iredell
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial.

Authors:  William H Yang; Marc Dionne; Michael Kyle; Naresh Aggarwal; Ping Li; Miguel Madariaga; Olivier Godeaux; David W Vaughn
Journal:  Vaccine       Date:  2013-07-12       Impact factor: 3.641

Review 10.  New vaccines against influenza virus.

Authors:  Young-Tae Lee; Ki-Hye Kim; Eun-Ju Ko; Yu-Na Lee; Min-Chul Kim; Young-Man Kwon; Yinghua Tang; Min-Kyoung Cho; Youn-Jeong Lee; Sang-Moo Kang
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18
View more
  65 in total

1.  Body mass index and infectious disease mortality in midlife in a cohort of 2.3 million adolescents.

Authors:  G Twig; N Geva; H Levine; E Derazne; N Goldberger; Z Haklai; A Leiba; J D Kark
Journal:  Int J Obes (Lond)       Date:  2017-10-30       Impact factor: 5.095

2.  Causal Isotonic Regression.

Authors:  Ted Westling; Peter Gilbert; Marco Carone
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2020-05-13       Impact factor: 4.488

3.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

Review 4.  Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.

Authors:  Anshu P Gounder; Adrianus C M Boon
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

5.  Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Krista M Goergen; Diane E Grill; Min-Hsin Chen; Lijuan Hao; Joseph Icenogle; Gregory A Poland
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

Review 6.  Influences of obesity on the immunogenicity of Hepatitis B vaccine.

Authors:  Fang Liu; Zhirong Guo; Chen Dong
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

7.  What Controls the Acute Viral Infection Following Yellow Fever Vaccination?

Authors:  James Moore; Hasan Ahmed; Jonathan Jia; Rama Akondy; Rafi Ahmed; Rustom Antia
Journal:  Bull Math Biol       Date:  2017-11-06       Impact factor: 1.758

8.  Vitamin A Corrects Tissue Deficits in Diet-Induced Obese Mice and Reduces Influenza Infection After Vaccination and Challenge.

Authors:  Rhiannon R Penkert; Valerie Cortez; Erik A Karlsson; Brandi Livingston; Sherri L Surman; Yaqi Li; A Catharine Ross; Stacey Schultz-Cherry; Julia L Hurwitz
Journal:  Obesity (Silver Spring)       Date:  2020-08-10       Impact factor: 5.002

Review 9.  Antimicrobial Dosing in Specific Populations and Novel Clinical Methodologies: Obesity.

Authors:  Manjunath P Pai
Journal:  Clin Pharmacol Ther       Date:  2021-02-28       Impact factor: 6.875

Review 10.  Adult preventive vaccines with other synergistic lifestyle options: is it time to add these ancillary benefits to the overall AS management checklist?

Authors:  Mark A Moyad
Journal:  World J Urol       Date:  2021-05-07       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.